Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies

Open Access Meeting abstract

Characterization of chromatographic yeast extract fractions promoting CHO cell growth

Mathilde Mosser12, Romain Kapel1, Arnaud Aymes1, Laurent-Michel Bonanno2, Eric Olmos1, Iris Besançon2, Dominique Druaux2, Isabelle Chevalot1, Ivan Marc1 and Annie Marc1*

Author Affiliations

1 Laboratoire Réactions et Génie des Procédés, UPR CNRS 3349, Nancy-Université, Vandœuvre-lès-Nancy, France

2 Bio Springer, Maisons-Alfort, France

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 8):P99  doi:10.1186/1753-6561-5-S8-P99


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/5/S8/P99


Published:22 November 2011

© 2011 Mosser et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background

Many studies underline the great benefits of yeast extracts (YE), used as supplements in animal free culture media, on cell growth and recombinant protein production [1,2]. Nevertheless, their unknown composition and batch-to-batch variability of commercial YE remain constraints for industrial processes [3,4]. Consequently, the identification of bioactive YE molecules is challenging for process reliability. The main strategy to respond upon this problem is to fractionate the extract and then to characterize the fractions. So far, several fractionation processes such as ultrafiltration [5], gel filtration chromatography [6] or alcoholic precipitation [7] have been investigated. These studies suggested that the active components were mainly small molecules (< 1000 Da). But, the other physico-chemical properties of YE components have been poorly studied until now. In regards of this statement, it is proposed to get better knowledge of the YE molecules leading to an improvement of CHO cell growth, by implementing various chromatographic fractionation processes.

Material and methods

CHO-AMW cell line producing anti-human RhD-IgG1 was provided by Dr. F. Wurm. Cell growth assays were performed in 96-well plates with 200 μL of working volume inside an incubator at 37 °C and 5 % CO2. Cells were cultivated in a protein-free chemically defined medium RPMI 1640/BDM (90/10) supplemented with 4 mM of glutamine (Eurobio, France) and supplemented or not by 1 g.L-1 of YE fraction. Cell concentration was in-situ monitored by Cellscreen® analyser (Innovatis, Germany).

Raw YE, the soluble fraction of yeast autolysate, was provided by BioSpringer. A nanofiltration step using Nanomax 50 membrane (Millipore, Bedford, MA) was used to remove the very small molecules such as salts and amino acids. YE was first fractionated by three one-step preparative chromatographies according to the described conditions (Table 1). Fractions containing salts and buffers were purified and concentrated by nanofiltration. In another way, a complete chromatographic fractionation was achieved by sequentially separating YE with anion-exchange, hydrophobic interaction and size exclusion chromatography. All fractions were lyophilized for further analyses and cell culture assays.

Table 1. Operating conditions of preparative chromatographic fractionations.

Concentration of total amino acids, polysaccharides and nucleic acids were determined in all fractions by HPLC methods after total hydrolysis. Molecular weights were evaluated by size-exclusion HPLC [8].

Results

Firstly, the YE was separately fractionated either by anion exchange (AEC), hydrophobic interaction (HIC) or gel filtration chromatography (GFC). The AEC allowed isolating in one fraction the nucleic acids strongly bound to the gel, while peptides were distributed among all fractions depending on their electrical charges. In the HIC fractions, important quantities of buffer salts still remained despite the desalting process. Finally, the GFC led to three fractions containing various proportions of nucleic acids, polysaccharides and peptides. Then, the influence of the fractions on the CHO cell growth was evaluated in 96-well microplates (Figure 1-A). All GFC fractions presented similar results than raw YE. The HIC fractions did not stimulate the cell growth, probably due to residual buffer salts. Furthermore, only one fraction from AEC, devoid of nucleic acids but enriched in positive-charged peptides, presented a similar impact than YE.

thumbnailFigure 1. Maximal concentration of CHO cells with or without 1 g.L-1 of YE fractions obtained (A) by one-step and (B) three-step chromatography. The control culture was performed in the chemically-defined medium.

Secondly, YE was divided in 18 fractions by a global process including the three chromatographic methods in a sequential mode: AEC, HIC, GFC. The final GF step presented the advantage to remove the residual salts. The cell growth monitoring pointed out two fractions, which led to similar results than the YE (Figure 1-B). These fractions contained peptides, mainly positively charged and polar, low quantities of polysaccharides but no nucleic acids. The amino acids quantification of fraction A.1-H.1-W.3 underlined that peptides were mainly composed of lysine and arginine. This result was consistent with a recent patent claiming that C-terminal arginine containing tripeptides were at least partially responsible for the growth promoting activity of a peptone (9).

Conclusion

A one step-fractionation process by anion exchange chromatography led to a simplified composition of raw YE without compromising its stimulating effect on CHO cell growth. Furthermore, the three-step fractionation process allowed a better knowledge of the physico-chemical properties of the molecules involved in cell growth stimulating effects: polar positively charged and mainly composed of peptides enriched in arginine and lysine residues.

References

  1. Sung YH, Lim SW, Chung JY, Lee GM: Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells.

    Appl Microbiol Biot 2004, 63:527-536. Publisher Full Text OpenURL

  2. Kim DY, Lee JC, Chang HN, Oh DJ: Development of serum-free media for a recombinant CHO cell line producing recombinant antibody.

    Enzyme Microb Tech 2006, 39:426-433. Publisher Full Text OpenURL

  3. Butler M: Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.

    Appl Microbiol Biot 2005, 68:283-291. Publisher Full Text OpenURL

  4. Grillberger L, Kreil TR, Nasr S, Reiter M: Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

    Biotechnol J 2009, 4:186-201. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  5. Chun BH, Kim JH, Lee HJ, Chung N: Usability of size-excluded fractions of soy protein hydrolysates for growth and viability of Chinese hamster ovary cells in protein-free suspension culture.

    Bioresource Technol 2007, 98:1000-1005. Publisher Full Text OpenURL

  6. Mendonça RZ, Oliveira EC, Pereira CA, Lebrun I: Effect of bioactive peptides isolated from yeastolate, lactalbumin and NZCase in the insect cell growth.

    Bioprocess Biosyst Eng 2007, 30:157-164. PubMed Abstract | Publisher Full Text OpenURL

  7. Shen CF, Kiyota T, Jardin B, Konishi Y, Kamen A: Characterization of yeastolate fractions that promote insect cell growth and recombinant protein production.

    Cytotechnology 2007, 54:25-34. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Chabanon G, Alves da Costa L, Farges B, Harscoat C, Chenu S, Goergen JL, Marc A, Marc I, Chevalot I: Influence of the rapeseed protein hydrolysis process on CHO cell growth.

    Bioresource Technol 2008, 99:7143-7151. Publisher Full Text OpenURL

  9. Wilkins J: Biologically active c-terminal arginine-containing peptides.

    United states patent application 2009.

    US 2009/0143248 A1

    OpenURL